Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Thomas R. Beam"'
Autor:
Thomas R. Beam
Publikováno v:
Critical Care Nursing Clinics of North America. 6:275-293
Anti-infective drugs may be used to prevent or treat infectious diseases. Preventing serious infections using aerosolized drugs, selective decontamination of the intestinal tract, or devices impregnated with anti-infective materials generally has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2083dcec7655b4b0172b1ece4c7a87ec
https://doi.org/10.1016/s0899-5885(18)30492-1
https://doi.org/10.1016/s0899-5885(18)30492-1
Publikováno v:
Journal of Antimicrobial Chemotherapy. 33:1060-1064
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927fb7ac25ac583235715a5237ac8817
https://doi.org/10.1093/jac/33.5.1060
https://doi.org/10.1093/jac/33.5.1060
Publikováno v:
Clinical Infectious Diseases. 15:S5-S32
This document provides new general guidelines for the design and execution of studies evaluating anti-infective drugs for the prevention or treatment of infectious diseases. The first step in evaluation is the determination of in vitro microbial susc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a355f72eb0d13b61ae98a6bbb0e3dd6b
https://doi.org/10.1093/clind/15.supplement_1.s5
https://doi.org/10.1093/clind/15.supplement_1.s5
Publikováno v:
Clinical Infectious Diseases. 14:S246-S251
The evaluation of antibacterial therapy for urinary tract infection (UTI) is based on the results of randomized, controlled comparative studies (preferably double-blinded) in which sufficient numbers of patients are entered into both arms to ensure s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d15a0e851cf513469a89d82d8f8b987
https://doi.org/10.1093/clinids/14.supplement_2.s246
https://doi.org/10.1093/clinids/14.supplement_2.s246
Publikováno v:
Clinical Infectious Diseases. 13:S890-S894
This article describes the current collaborative effort of the U.S. Food and Drug Administration and the Infectious Diseases Society of America to generate new general and disease/organism-specific guidelines for the evaluation of anti-infective agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71757bbda22a1d23a9d1658533a1fa9d
https://doi.org/10.1093/clinids/13.supplement_10.s890
https://doi.org/10.1093/clinids/13.supplement_10.s890
Publikováno v:
Antimicrobic Newsletter. 7:1-4
The 1977 Guidelines for the Evaluation of Anti-infective Drug Products are no longer useful. The IDSA has established a contract with the FDA to revise and update these documents. Thirteen sub-committees will address specific areas of infectious dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c6dc44d8320e42f1108854175a941ef
https://doi.org/10.1016/0738-1751(90)90022-5
https://doi.org/10.1016/0738-1751(90)90022-5
Publikováno v:
Drug Information Journal. 24:225-229
For the past decade, one of the most active areas in drug development has been the introduction of new anti- infective drug products. Determination of safety and efficacy by the Food and Drug Administration are guided by the General Considerations fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff7d693ff18965a1463250288b9ab84d
https://doi.org/10.1177/009286159002400134
https://doi.org/10.1177/009286159002400134
Publikováno v:
Diagnostic microbiology and infectious disease. 17(1)
The in vitro activity of sparfloxacin was compared with the activities of ciprofloxacin, ofloxacin, and six other antimicrobial agents against 323 bloodstream isolates of staphylococci (both oxacillin susceptible and resistant) enterococci, and pneum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42be3e527ce10973d05b4c9fb5551f7
https://pubmed.ncbi.nlm.nih.gov/8395375
https://pubmed.ncbi.nlm.nih.gov/8395375
Autor:
Coleman Rotstein, Theresa Lawrence, Daniel Amsterdam, Thomas R. Beam, Lionel A. Mandell, E A Gorzynski
Publikováno v:
The Journal of antimicrobial chemotherapy. 28
Temafloxacin, a new fluoroquinolone with enhanced activity against Gram-positive bacteria, was compared with other antibiotics. A review of the literature on the in-vitro activity of temafloxacin was also done. The susceptibility of Gram-positive coc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdf60d1eba57357b78d18981ecbc22f
https://pubmed.ncbi.nlm.nih.gov/1664826
https://pubmed.ncbi.nlm.nih.gov/1664826